Indivior Pharmaceuticals Inc. (INDV)
INDV trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$35.42
-1.77% on the day
Market cap
$4.2B
Mid cap
Revenue · 2025
$1.2B
+4.3% on 2024
Net income · 2025
$210.0M
16.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | INDV on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United Kingdom |
| IPO year | Not reported by the screener |
| SEC CIK | 0001625297 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.2B |
| Net income | $210.0M |
| Operating income | $262.0M |
| Net margin | 16.9% |
| Operating margin | 21.1% |
| Revenue growth | +4.3% |
| Cash | $195.0M |
| Total assets | $1.2B |
| P/E (computed) | 19.9× |
| P/S (computed) | 3.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2026-09-11 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-03 |
| Latest current report FORM 8-K | 8-K | 2026-10-06 |
| Latest proxy | DEFA14A | 2026-03-27 |
Source: SEC EDGAR submissions feed, 548 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.2% |
| 1 month | +1.2% |
| 3 months | -14.7% |
| Year to date | -3.5% |
| 1 year | +45.0% |
| From 52-week high | -17.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ABCL | AbCellera Biologics Inc. Common Shares | $12.61 | -0.20% | $4.1B |
| DNTH | Dianthus Therapeutics Inc. | $77.58 | -4.89% | $4.3B |
| EWTX | Edgewise Therapeutics Inc. | $36.28 | -5.64% | $3.9B |
| TNGX | Tango Therapeutics Inc. | $22.22 | -8.07% | $3.7B |
| TLX | Telix Pharmaceuticals Limited | $10.92 | -3.28% | $3.7B |
| OGN | Organon & Co. Common Stock | $13.77 | 0.00% | $3.6B |
| MANE | Veradermics Incorporated | $116.26 | -5.02% | $4.9B |
| COGT | Cogent Biosciences Inc. | $28.09 | -5.67% | $4.9B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier